800-331-6634

Annual American Academy of Ophthalmology Conference 2018

By http://www.midatlanticretina.com/author
November 1, 2018

The annual American Academy of Ophthalmology Conference was held in Chicago, IL on October 26-29, 2018, and a number of our Mid Atlantic Retina Doctors were in attendance.  Dr. Carl Regillo presented findings from the clinical trial (LADDER trial) on a refillable ranibizumab implant that could allow patients with wet AMD to go 6 months or more between visits.  Read this article or watch his video to learn more about the new port delivery system.

Throughout the two days of Retina Subspecialty, Dr. Chiang presented a scientific poster on "Patients Ultra-Responsive to Ranibizumab Treatment in DRCR.Net Protocol S”. Dr. Ho was a Surgeon Panelist for the “My Coolest Surgical Video” presentations, where he judged and graded different presentations. Also, Dr. Ho acted as an AAO Retina Society Symposium Moderator for the “Cutting Edge Therapies for Common Diseases” presentation. Dr. Hsu was a course instructor alongside Dr. Garg, as the senior instructor, for the “Advanced Vitreoretinal Surgery Techniques”, an interactive case-based course teaching other retinal specialists strategies in vitreoretinal surgery. Dr. Hsu also served as an expert for a course on “Managing Complex Secondary Intraocular Lenses. In addition to his presentation on the LADDER study, Dr. Regillo presented on two topics, “How Targeting the Tie2 Pathway May Affect Current Treatment Paradigms in nAMD - Current Insights” and “Emerging Wet AMD Treatments”.

 

Category:


Comments are closed.